| Mrs Judith Paige Smith, OTR/L | |
|
3701 Landsdowne Dr, Ashland, KY 41102-5422 | |
| (606) 324-3005 | |
| Not Available |
| Full Name | Mrs Judith Paige Smith |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 25 Years |
| Location | 3701 Landsdowne Dr, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629279542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XM0800X | Occupational Therapist - Mental Health | 133747 (Kentucky) | Secondary |
| 225X00000X | Occupational Therapist | 133747 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathways Inc | 1254239171 | 36 |
News Archive
The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.
Cigna and Hunterdon Healthcare Partners, LLC, a physician hospital organization (PHO) affiliated with Hunterdon Healthcare, have launched a collaborative accountable care initiative to improve patient access to health care, enhance care coordination, and achieve the "triple aim" of improved health, affordability and patient experience.
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
› Verified 8 days ago
| Provider Name | Pathways Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982615043 PECOS PAC ID: 1254239171 Enrollment ID: O20031230000043 |
News Archive
The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.
Cigna and Hunterdon Healthcare Partners, LLC, a physician hospital organization (PHO) affiliated with Hunterdon Healthcare, have launched a collaborative accountable care initiative to improve patient access to health care, enhance care coordination, and achieve the "triple aim" of improved health, affordability and patient experience.
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Judith Paige Smith, OTR/L Po Box 790, Ashland, KY 41105-0790 Ph: (606) 329-8588 | Mrs Judith Paige Smith, OTR/L 3701 Landsdowne Dr, Ashland, KY 41102-5422 Ph: (606) 324-3005 |
News Archive
The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.
Cigna and Hunterdon Healthcare Partners, LLC, a physician hospital organization (PHO) affiliated with Hunterdon Healthcare, have launched a collaborative accountable care initiative to improve patient access to health care, enhance care coordination, and achieve the "triple aim" of improved health, affordability and patient experience.
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
› Verified 8 days ago
Sahvannah Mcdowell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12862 State Route 180, Ashland, KY 41102 Phone: 606-928-5805 | |
Kevin Duaine Duncan, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 13th Street, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-9848 | |
Amy Kennedy, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-326-2878 | |
Sensational Kids Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Kilgore Dr, Ashland, KY 41101 Phone: 606-831-8752 | |
Mrs. Jackie Lynn Martin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Kilgore Dr, Ashland, KY 41101 Phone: 606-831-8752 | |
Keri Beth Schwamberger, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 13th Street, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-9848 | |
Alexandrea Ballard, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5850 Us-60, Suite B-d, Ashland, KY 41101 Phone: 606-325-1528 |